Prayer #351: For a New Study of the Pfizer Vaccine's Effectiveness in Preventing Both Symptomatic and Asymptomatic COVID-19 Infection
The Ministry of Health of Israel recently completed an independent study of the Pfizer vaccine's effectiveness in preventing both symptomatic and asymptomatic infections of COVID-19. The investigation looked at data from people vaccinated in Israel from January 17 to March 6, a period in which only the Pfizer vaccine was available in that country, and, significantly, when the B.1.1.7 variant, believed to be more contagious than the original COVID strain, was the dominant strain in Israel. According to this study, the vaccine was at least 97% effective against symptomatic COVID-19 infection and 94% effective against asymptomatic infection. This, health officials believe, is important "real-world evidence" of the efficacy of this vaccine. "We are extremely encouraged that the real-world effectiveness data coming from Israel are confirming the high efficacy demonstrated in our Phase 3 clinical trial and showing the significant impact of the vaccine in preventing severe disease and deaths due to COVID-19," Dr. Luis Jodar, senior vice president and chief medical officer of Pfizer stated in a press release. "The findings which suggest that the vaccine may also provide protection against asymptomatic SARS-CoV-2 infections are particularly meaningful as we look to disrupt the spread of the virus around the globe. Altogether, these data are critical to understanding the role of vaccination in combatting the pandemic and provide hope to other countries dealing with this devastating disease, which has now afflicted the world for more than a year."
We do thank God for the results of this study of the effectiveness of the Pfizer vaccine for COVID-19. Continue to pray for the vaccinations to proceed quickly across our country and around the globe, and that the COVID cases, hospitalizations, and deaths from the virus would continue to plummet.
Ps. 16:1: "Preserve me, O God, for in Thee I take refuge."